Anti-tumor necrosis factor treatment from diagnosis is more effective and less costly than conventional "step-up" care for patients with active Crohn's disease: a cost-effectiveness analysis from the PROFILE trial.
Saved in:
| Title: | Anti-tumor necrosis factor treatment from diagnosis is more effective and less costly than conventional "step-up" care for patients with active Crohn's disease: a cost-effectiveness analysis from the PROFILE trial. |
|---|---|
| Authors: | Noor, Nurulamin M1,2 (AUTHOR), Davies, Neil3 (AUTHOR), Tahir, Warda3 (AUTHOR), Bond, Simon4 (AUTHOR), Dowling, Francis4 (AUTHOR), Patel, Kamal V5 (AUTHOR), Lyons, Paul A2,6 (AUTHOR), McKinney, Eoin F2,6 (AUTHOR), Smith, Kenneth G C7,8 (AUTHOR), Lee, James C9,10 (AUTHOR), Buchanan, Vanessa3 (AUTHOR), Parkes, Miles1,2 (AUTHOR), Group, PROFILE Study (AUTHOR) |
| Source: | Journal of Crohn's & Colitis. Sep2025, Vol. 19 Issue 9, p1-12. 12p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
